Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VEGFR2/CD309 Antikörper (pTyr951)

Der Kaninchen Polyklonal Anti-VEGFR2/CD309 Antikörper wurde für WB, ELISA, IF und IHC (p) validiert. Er ist geeignet, VEGFR2/CD309 in Proben von Human und Maus zu detektieren.
Produktnummer ABIN7222022
-15% Promotion 2026
530,08 €
623,62 €
Sparen Sie 93,54 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 10 bis 14 Werktagen

Kurzübersicht für VEGFR2/CD309 Antikörper (pTyr951) (ABIN7222022)

Target

Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigen
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reaktivität

  • 340
  • 214
  • 143
  • 17
  • 9
  • 5
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus

Wirt

  • 296
  • 67
  • 42
  • 14
  • 1
  • 1
  • 1
Kaninchen

Klonalität

  • 277
  • 145
Polyklonal

Konjugat

  • 182
  • 34
  • 20
  • 16
  • 14
  • 10
  • 10
  • 8
  • 8
  • 8
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser VEGFR2/CD309 Antikörper ist unkonjugiert

Applikation

  • 220
  • 120
  • 111
  • 111
  • 62
  • 35
  • 26
  • 25
  • 22
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 6
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Bindungsspezifität

    • 39
    • 33
    • 26
    • 23
    • 21
    • 16
    • 16
    • 11
    • 11
    • 10
    • 9
    • 9
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr951

    Verwendungszweck

    Flk-1 (phospho Tyr951) Polyclonal Antibody

    Spezifität

    Phospho-Flk-1 (Y951) Polyclonal Antibody detects endogenous levels of Flk-1 protein only when phosphorylated at Y951.

    Aufreinigung

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen

    Immunogen

    Synthesized peptide derived from human Flk-1 Phospho-Tyr951

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), IHC-P (1:100-1:300), IF (1:200-1:1000), ELISA (1:20000). Not yet tested in other applications.

    Kommentare

    Primary Antibody

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
  • Target

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    Andere Bezeichnung

    Flk-1

    Hintergrund

    Rabbit Anti-Flk-1 (phospho Tyr951) Polyclonal Antibody,KDR, FLK1, VEGFR2, Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, FLK-1, Kinase insert domain receptor, KDR, Protein-tyrosine kinase receptor flk-1, CD antigen CD309,VEGF R1 is one of the five receptor tyrosine kinases (RTKs) (Flt-1, KDR/Flk-1, Flt-4, tie-1, and tek/tie-2) whose expression is almost exclusively restricted to the endothelial cells. Tie-1 and tek/tie-2 define a new class of RTKs containing two immunoglobulin-like domains, three EGF homology domains and three fibronectin type III domains in their extracellular regions. Flt-1, KDR/Flk-1 and Flt-4 are members of the class III subfamily of RTKs containing seven immunoglobulin-like repeats in their extracellular domains. All five RTKs are likely to play central roles in vasculogenesis and angiogenesis.,Vascular endothelial growth factor receptor 2

    Gen-ID

    3791

    UniProt

    P35968

    Pathways

    RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Sie sind hier:
Chat with us!